These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 19134264)

  • 41. Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation.
    Davin JC; Gracchi V; Bouts A; Groothoff J; Strain L; Goodship T
    Am J Kidney Dis; 2010 Apr; 55(4):708-11. PubMed ID: 19854549
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Complement factor h gene abnormalities in haemolytic uraemic syndrome: from point mutations to hybrid gene.
    Noris M; Remuzzi G
    PLoS Med; 2006 Oct; 3(10):e432. PubMed ID: 17076562
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome.
    Vaziri-Sani F; Holmberg L; Sjöholm AG; Kristoffersson AC; Manea M; Frémeaux-Bacchi V; Fehrman-Ekholm I; Raafat R; Karpman D
    Kidney Int; 2006 Mar; 69(6):981-8. PubMed ID: 16528247
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic disorders in complement (regulating) genes in patients with atypical haemolytic uraemic syndrome (aHUS).
    Westra D; Volokhina E; van der Heijden E; Vos A; Huigen M; Jansen J; van Kaauwen E; van der Velden T; van de Kar N; van den Heuvel L
    Nephrol Dial Transplant; 2010 Jul; 25(7):2195-202. PubMed ID: 20106822
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel use of intravenous immunoglobulin is not restricted to complement hypercatabolism because of factor H deficiency.
    Späth PJ
    Prog Transplant; 2014 Jun; 24(2):120. PubMed ID: 24919726
    [No Abstract]   [Full Text] [Related]  

  • 46. Atypical hemolytic uremic syndrome due to factor H autoantibody.
    Uslu-Gökceoğlu A; Doğan CS; Comak E; Koyun M; Akman S
    Turk J Pediatr; 2013; 55(1):86-9. PubMed ID: 23692839
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidemiological approach to identifying genetic predispositions for atypical hemolytic uremic syndrome.
    Sullivan M; Erlic Z; Hoffmann MM; Arbeiter K; Patzer L; Budde K; Hoppe B; Zeier M; Lhotta K; Rybicki LA; Bock A; Berisha G; Neumann HP
    Ann Hum Genet; 2010 Jan; 74(1):17-26. PubMed ID: 20059470
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Successful (?) therapy of hemolytic-uremic syndrome with factor H abnormality.
    Gerber A; Kirchhoff-Moradpour AH; Obieglo S; Brandis M; Kirschfink M; Zipfel PF; Goodship JA; Zimmerhackl LB
    Pediatr Nephrol; 2003 Sep; 18(9):952-5. PubMed ID: 12836093
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Complement dysregulation in haemolytic uraemic syndrome.
    Bonnardeaux A; Pichette V
    Lancet; 2003 Nov; 362(9395):1514-5. PubMed ID: 14615103
    [No Abstract]   [Full Text] [Related]  

  • 50. A mouse model of non-Shiga toxin-associated haemolytic uraemic syndrome.
    Caprioli J; Remuzzi G
    Nephrol Dial Transplant; 2008 Feb; 23(2):462-5. PubMed ID: 17956888
    [No Abstract]   [Full Text] [Related]  

  • 51. Hemolytic-uremic syndrome: hereditary forms and forms associated with hereditary diseases.
    Niaudet P; Gagnadoux MF; Broyer M; Salomon R
    Adv Nephrol Necker Hosp; 2000; 30():261-80. PubMed ID: 11068647
    [No Abstract]   [Full Text] [Related]  

  • 52. Hereditary hemolytic uremic syndrome.
    Carreras L; Caralps A; Martínez Amenós A; Rama H; Alsina J
    Nephron; 1983; 34(4):269. PubMed ID: 6877464
    [No Abstract]   [Full Text] [Related]  

  • 53. The development of atypical hemolytic uremic syndrome is not influenced by thrombophilia susceptibility factors.
    Kemp EJ; Strain L; Diaz-Torres ML; Goodship JA; Goodship TH
    J Thromb Haemost; 2005 Sep; 3(9):2128-30. PubMed ID: 16102133
    [No Abstract]   [Full Text] [Related]  

  • 54. Familial hemolytic-uremic syndrome.
    Goodyer PR; Fraser FC
    J Pediatr; 1990 Feb; 116(2):316. PubMed ID: 2299509
    [No Abstract]   [Full Text] [Related]  

  • 55. Hemolytic-uremic syndrome in two siblings from a nonendemic area.
    Hymes LC; Warshaw BL
    Am J Dis Child; 1981 Aug; 135(8):766-7. PubMed ID: 7270524
    [No Abstract]   [Full Text] [Related]  

  • 56. [Atypical hemolytic uremic syndrome and the CFH gene].
    Jiang CR; Ye LY; Yu ZH
    Zhonghua Er Ke Za Zhi; 2008 Dec; 46(12):952-5. PubMed ID: 19134264
    [No Abstract]   [Full Text] [Related]  

  • 57. Atypical hemolytic uremic syndrome: telling the difference between H and Y.
    Goicoechea de Jorge E; Pickering MC
    Kidney Int; 2010 Oct; 78(8):721-3. PubMed ID: 20877372
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of compound heterozygous complement factor H mutations on development of atypical hemolytic uremic syndrome-A pedigree revisited.
    Johnson SA; Williams JM; Hakobyan S; Richards A; Perkins SJ; Marchbank KJ; Goodship TH; Morgan BP; Taylor CM; Savage CO
    Mol Immunol; 2010 Apr; 47(7-8):1585-91. PubMed ID: 20304497
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Atypical haemolytic-uraemic syndrome due to heterozygous mutations of CFH/CFHR1-3 and complement factor H 479.
    Chaudhary P; Hepgur M; Sarkissian S; Smith RJ; Weitz IC
    Blood Transfus; 2014 Jan; 12(1):111-3. PubMed ID: 24333077
    [No Abstract]   [Full Text] [Related]  

  • 60. Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome.
    Kavanagh D; Richards A; Fremeaux-Bacchi V; Noris M; Goodship T; Remuzzi G; Atkinson JP
    Clin J Am Soc Nephrol; 2007 May; 2(3):591-6. PubMed ID: 17699467
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.